Patents - Global Data - Dimensions
SYNTHETIC COMPOSITION COMPRISING ONE OR MORE HUMAN MILK OLIGOSACCHARIDES (HMOS)
Applicants:
- GLYCOM AS [NORA names: Glycom; Private Research]
Abstract
A method and a composition comprising human milk oligosaccharides for decreasing the production of detrimental proteolytic metabolites such as ammonia and branched chain fatty acids in the intestinal microbiota of humans, which is useful for the treatment of brain-gut disorders like autism, stress, anxiety, and depressive disorders, are disclosed. Methods of treatment of colon cancer and liver damage are also disclosed.
Patent Family Records (5)
HMO compositions and methods for reducing detrimental proteolytic metabolites
Glycom AS VIGSNÆS LOUISE KRISTINE, MCCONNELL BRUCE
2023, US-11541067-B2
SYNTHETIC COMPOSITION COMPRISING ONE OR MORE HUMAN MILK OLIGOSACCHARIDES (HMOS)
Glycom AS VIGSNÆS LOUISE KRISTINE, MCCONNELL BRUCE
2020, US-20200155580-A1
SYNTHETIC COMPOSITION COMPRISING ONE OR MORE HUMAN MILK OLIGOSACCHARIDES (HMOS)
Glycom AS VIGSNÆS LOUISE KRISTINE, MCCONNELL BRUCE
2020, EP-3630123-A4
SYNTHETIC COMPOSITION COMPRISING ONE OR MORE HUMAN MILK OLIGOSACCHARIDES (HMOS)
Glycom AS VIGSNÆS LOUISE KRISTINE, MCCONNELL BRUCE
2020, EP-3630123-A1
SYNTHETIC COMPOSITION COMPRISING ONE OR MORE HUMAN MILK OLIGOSACCHARIDES (HMOS)
GLYCOM AS VIGSNÆS LOUISE KRISTINE, MCCONNELL BRUCE
2018, WO-2018215960-A1
